Patents Assigned to ELIXIRON IMMUNOTHERAPEUTICS (HONG KONG) LIMITED
  • Patent number: 10968274
    Abstract: Provided is an anti-INF-? antibody. Also provided are a composition comprising the antibody and a pharmaceutical application of the antibody in treating IFN-? mediated syndrome.
    Type: Grant
    Filed: May 7, 2018
    Date of Patent: April 6, 2021
    Assignee: Elixiron Immunotherapeutics (Hong Kong) Limited
    Inventors: Cheng-Lun Ku, Han-Po Shih, Chia-Hao Lin, Jing-Ya Ding, Jing-Yi Huang, Yi-Ting Kuo
  • Patent number: 10813974
    Abstract: The present invention provides methods for treating hepatitis B virus (HBV) infection using antibodies which specifically bind to human IFN?.
    Type: Grant
    Filed: June 1, 2020
    Date of Patent: October 27, 2020
    Assignee: ELIXIRON IMMUNOTHERAPEUTICS (HONG KONG) LIMITED
    Inventors: Hung-Kai Chen, Daw-Tsun Shih, Cheng-Lun Ku, Pei-Han Chung
  • Publication number: 20200289603
    Abstract: The present invention provides methods for treating hepatitis B virus (HBV) infection using antibodies which specifically bind to human IFN?.
    Type: Application
    Filed: June 1, 2020
    Publication date: September 17, 2020
    Applicant: ELIXIRON IMMUNOTHERAPEUTICS (HONG KONG) LIMITED
    Inventors: Hung-Kai CHEN, Daw-Tsun SHIH, Cheng-Lun KU, Pei-Han CHUNG